Using light therapy to relieve chronic knee pain in obese patients preparing for weight loss surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of photobiomodulation (PBM) therapy in reducing chronic knee pain and improving functionality in obese patients who are preparing for bariatric surgery. It is a double-blind, randomized, placebo-controlled trial that will assess pain intensity and knee function through various validated measures. The study aims to determine if PBM can serve as an effective analgesic treatment and modify pain pathways in this specific patient population. Participants will receive either active PBM treatment, standard physiotherapy, or a placebo treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Obese patients with indication for bariatric surgery performed in routine follow-up at the Gastric Surgery Outpatient Clinic of HC-UFG;
* Patients with chronic pain (\> 3 months) in the knees bilaterally. Patients will be asked in the initial evaluation if they feel pain located in the topography of the knees that has been compromising their functionality both in daily activities and at work, and that lasts for more than or equal to 3 months. This pain may be reported as continuous or intermittent;
* Sign the Informed Consent Term approved by the HC-UFG Ethics Committee.

Exclusion Criteria:

* \- Loss of follow-up in the outpatient clinic of origin and in the Physiotherapy sector, even though the use of laser therapy was maintained according to the study protocol;
* Any reported adverse effects from the use of FBM reported;
* Patients in whom there are changes in the medications being used for chronic pain during the study protocol will be excluded from this study. Minimal changes in the dosages of medications already in use can be tolerated, as long as there are no changes in the type of medication, but only in the prescribed dose. These modifications throughout the study, if they occur, will be described.
* Death
* Withdrawal of the informed consent by the participant
* If the patient, for any reason, is excluded from the indication of bariatric surgery
* Emergence during the study of any of the non-inclusion criteria, like: .
* Patients with other rheumatologic diseases and/or systemic inflammatory diseases (rheumatoid arthritis, Reiter's arthritis, ankylosing spondylitis, generalized polyarthritis) or previous musculoskeletal diseases in the knees;
* Clinical manifestations or complaints of knee arthralgia related to diseases other than obesity.
* Previous use in the last 90 days of treatment with the use of Phototherapy for the same or another indication;
* Clinical signs of neuropathy, including radiculopathies and peripheral nerve injuries;
* Pain in the lower limb, originating from the lumbar spine (lombosciatalgia)
* Use of corticosteroids at an immunosuppressive dose (20mg daily of prednisone or equivalent for at least 14 days);
* Infection or tumor at the site of therapy application;
* Current chronic infections such as tuberculosis or chronic hepatitis treated or not.
* Blood clotting disorders (including thrombosis) at the application site.
* Diagnosis of fibromyalgia;
* Serious psychiatric disorders that require psychiatric care;
* Systemic injections and/or joint injections of corticosteroids or hyaluronic acid during the last 48 hours prior to the initial assessment of the study;
* Psychoaffective disorder that compromises adherence to treatment;
* Any history of sensitivity to light or phototherapies.

Where it's running

• Gastric Outpatient Clinic of HC-UFG
  Goiânia, Goiás, Brazil Recruiting

Study contacts

• Principal investigator: Rebeca B Cecatto, MD PHD — Nove de Julho University
• Study coordinator: Rebeca B Cecatto, MD PHD
• Email: rebeca.boltes@uni9.pro.br
• Phone: +5511970842496

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Glycemic variability after SASI versus Roux-en-Y gastric bypass

  This trial tests whether SASI or Roux-en-Y gastric bypass leads to different glucose fluctuations in adults with severe obesity using continuous glucose monitoring.

  Recruiting Hospitales Universitarios Virgen del Rocío · Seville, Sevilla · NCT07872397

• Postoperative nausea, vomiting and pain after bariatric surgery in Sweden

  This study looks at how often people have nausea, vomiting, and pain after bariatric surgery in Sweden and whether anesthesia type or regional blocks affect those outcomes.

  Recruiting at 2 sites Umeå University · Sundsvall and 1 other locations · NCT07797374

• Personalized pain relief for knee OA using central nervous system-based duloxetine

  This study tests whether duloxetine can improve walking and daily activity in people with knee osteoarthritis by comparing it to a placebo.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07759336

• STAR & BMI: Can thigh muscle and fat measurements predict knee pain relief after a nerve block

  This study tests whether ultrasound measurements of thigh muscle and subcutaneous fat can help predict who will have pain relief after a genicular nerve block for knee osteoarthritis.

  Recruiting Gaziosmanpasa Research and Education Hospital · Istanbul · NCT07712419

• Nerve branches to the vastus medialis added to genicular nerve treatment for chronic knee pain

  This observational study tests whether adding pulsed radiofrequency to the nerve branches near the vastus medialis to standard genicular nerve treatment helps people with chronic knee osteoarthritis pain.

  Recruiting Diskapi Teaching and Research Hospital · Ankara · NCT07703293

• Why walking causes different amounts of knee pain in people with osteoarthritis

  This project will see if differences in the brain, joint imaging, movement, and sensory responses explain why adults 45–80 with knee osteoarthritis have different levels of walking pain.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07308873

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.